Kyri K. Van Hoose

Insider Reports History

Entity
Individual
Location
C/O Turning Point Therapeutics, Inc., 10628 Science Center Drive, Suite 200, San Diego, California
Signature
/s/ Gerald T. Proehl, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kyri K. Van Hoose:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Dermata Therapeutics, Inc. SVP, CFO Stock Option (right to buy) 50,000 Jan 4, 2024 Direct

Insider Reports Filed by Kyri K. Van Hoose

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DRMA Dermata Therapeutics, Inc. Jan 4, 2024 1 0 4 Jan 5, 2024 SVP, CFO
DRMA Dermata Therapeutics, Inc. Jan 3, 2023 1 0 4 Jan 5, 2023 SVP, CFO
DRMA Dermata Therapeutics, Inc. Jan 3, 2022 1 0 4 Jan 5, 2022 SVP, Chief Financial Officer
DRMA Dermata Therapeutics, Inc. Sep 1, 2021 1 0 4 Sep 1, 2021 Chief Financial Officer
DRMA Dermata Therapeutics, Inc. Sep 1, 2021 0 0 3 Sep 1, 2021 Chief Financial Officer
TPTX Turning Point Therapeutics, Inc. May 14, 2021 0 0 3 May 14, 2021 Principal Accounting Officer